NetraMark Holdings Inc.
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and chan… Read more
NetraMark Holdings Inc. (AINMF) - Net Assets
Latest net assets as of December 2025: $1.18 Million USD
Based on the latest financial reports, NetraMark Holdings Inc. (AINMF) has net assets worth $1.18 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.54 Million) and total liabilities ($354.99K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.18 Million |
| % of Total Assets | 76.94% |
| Annual Growth Rate | 0.09% |
| 5-Year Change | -76.9% |
| 10-Year Change | N/A |
| Growth Volatility | 179.79 |
NetraMark Holdings Inc. - Net Assets Trend (2020–2025)
This chart illustrates how NetraMark Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NetraMark Holdings Inc. (2020–2025)
The table below shows the annual net assets of NetraMark Holdings Inc. from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.83 Million | +1023.98% |
| 2024-09-30 | $-198.56K | -118.29% |
| 2023-09-30 | $1.09 Million | -86.62% |
| 2022-09-30 | $8.11 Million | +2.10% |
| 2021-09-30 | $7.94 Million | +334.91% |
| 2020-09-30 | $1.83 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to NetraMark Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4125435000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $43.38 Million | 2364.59% |
| Total Equity | $1.83 Million | 100.00% |
NetraMark Holdings Inc. Competitors by Market Cap
The table below lists competitors of NetraMark Holdings Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dong Yang Pipe
KO:008970
|
$70.14 Million |
|
SALTX TECHNOLOGY HLDG B
F:7X9
|
$70.19 Million |
|
111 Inc
NASDAQ:YI
|
$70.21 Million |
|
Epileds Technologies Inc
TW:4956
|
$70.22 Million |
|
Marisa Lojas S.A
SA:AMAR3
|
$70.12 Million |
|
NORDIC WATERPROOFING HLDG
F:9ZQ
|
$70.10 Million |
|
Fullerton Technology Co Ltd
TW:6136
|
$70.08 Million |
|
G2Power Co. Ltd.
KQ:388050
|
$70.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NetraMark Holdings Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -198,557 to 1,834,628, a change of 2,033,185.
- Net loss of 5,221,463 reduced equity.
- Other factors increased equity by 7,254,648.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.22 Million | -284.61% |
| Other Changes | $7.25 Million | +395.43% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares NetraMark Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 49.53x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 18.87x to 49.53x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | $0.06 | $1.04 | x |
| 2021-09-30 | $0.24 | $1.04 | x |
| 2022-09-30 | $0.19 | $1.04 | x |
| 2023-09-30 | $0.02 | $1.04 | x |
| 2024-09-30 | $0.00 | $1.04 | x |
| 2025-09-30 | $0.02 | $1.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NetraMark Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -284.61%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1207.29%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.19x
- Recent ROE (-284.61%) is above the historical average (-305.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -16.01% | 0.00% | 0.00x | 1.08x | $-475.12K |
| 2021 | -64.00% | 0.00% | 0.00x | 1.06x | $-5.88 Million |
| 2022 | -165.80% | -11897.34% | 0.01x | 1.13x | $-14.26 Million |
| 2023 | -1305.34% | -15872.69% | 0.05x | 1.76x | $-14.28 Million |
| 2024 | 0.00% | -730.45% | 2.20x | 0.00x | $-3.31 Million |
| 2025 | -284.61% | -1207.29% | 0.20x | 1.19x | $-5.40 Million |
Industry Comparison
This section compares NetraMark Holdings Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $87,920,505
- Average return on equity (ROE) among peers: -275.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NetraMark Holdings Inc. (AINMF) | $1.18 Million | -16.01% | 0.30x | $70.13 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |